Dyne Therapeutics, Inc. logo

DYN Earnings Date: Nov 4, 2026 (Estimated) — Dyne Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $16.60
Market Cap $3.1B
P/E -4.7
52W Range $14.00 – $27.30
Next Earnings · Before open (est.)

When is DYN's next earnings date?

Dyne Therapeutics, Inc. (DYN) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.91.

How did DYN do in its last earnings report?

In its most recent report on Jul 30, 2026, Dyne Therapeutics, Inc. posted EPS of -$1.08 versus the -$0.75 estimate, a miss. The stock's 1-day post-earnings move was +0.3%.

How much does DYN stock move after earnings?

DYN beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.0% (up or down) in the day after earnings.

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-07-30-0.75-1.08——❌ Miss+0.32%+4.26%+3.94%
2026-07-29Q2 2026-0.75-1.08-44.00%$0❌ Miss+2.51%+4.26%+3.94%
2026-05-11Q1 2026-0.77-0.73+5.19%$0✅ Beat+4.83%-1.82%+1.76%
2026-03-02Q4 2025-0.75-0.76-1.33%$0❌ Miss+3.39%-4.87%+9.41%
2025-11-05Q3 2025-0.83-0.76+8.43%$0✅ Beat-2.88%-8.60%-4.04%
2025-07-28Q2 2025-0.96-0.97-1.04%$0❌ Miss-1.18%+10.10%+43.72%
2025-02-27Q4 2024-0.75-0.88-17.33%$0❌ Miss-4.50%-11.68%-14.43%
2024-11-12Q3 2024-0.71-0.96-35.21%$0❌ Miss+4.27%+4.30%-2.35%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .